These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17315948)

  • 1. Structural characterization of the partially folded intermediates of an immunoglobulin light chain leading to amyloid fibrillation and amorphous aggregation.
    Qin Z; Hu D; Zhu M; Fink AL
    Biochemistry; 2007 Mar; 46(11):3521-31. PubMed ID: 17315948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates.
    Khurana R; Gillespie JR; Talapatra A; Minert LJ; Ionescu-Zanetti C; Millett I; Fink AL
    Biochemistry; 2001 Mar; 40(12):3525-35. PubMed ID: 11297418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The folding pathway of the antibody V(L) domain.
    Simpson ER; Herold EM; Buchner J
    J Mol Biol; 2009 Oct; 392(5):1326-38. PubMed ID: 19647749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural transformations of oligomeric intermediates in the fibrillation of the immunoglobulin light chain LEN.
    Souillac PO; Uversky VN; Fink AL
    Biochemistry; 2003 Jul; 42(26):8094-104. PubMed ID: 12834361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review: immunoglobulin light chain amyloidosis--the archetype of structural and pathogenic variability.
    Bellotti V; Mangione P; Merlini G
    J Struct Biol; 2000 Jun; 130(2-3):280-9. PubMed ID: 10940232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the folding and unfolding reactions of single-chain monellin: evidence for multiple intermediates and competing pathways.
    Patra AK; Udgaonkar JB
    Biochemistry; 2007 Oct; 46(42):11727-43. PubMed ID: 17902706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The amyloid fibrils of the constant domain of immunoglobulin light chain.
    Yamamoto K; Yagi H; Lee YH; Kardos J; Hagihara Y; Naiki H; Goto Y
    FEBS Lett; 2010 Aug; 584(15):3348-53. PubMed ID: 20580354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain.
    Davis DP; Gallo G; Vogen SM; Dul JL; Sciarretta KL; Kumar A; Raffen R; Stevens FJ; Argon Y
    J Mol Biol; 2001 Nov; 313(5):1021-34. PubMed ID: 11700059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vlambda6 proteins.
    Wall JS; Gupta V; Wilkerson M; Schell M; Loris R; Adams P; Solomon A; Stevens F; Dealwis C
    J Mol Recognit; 2004; 17(4):323-31. PubMed ID: 15227639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermodynamic and kinetic characterization of a germ line human lambda6 light-chain protein: the relation between unfolding and fibrillogenesis.
    Blancas-Mejia LM; Tellez LA; del Pozo-Yauner L; Becerril B; Sanchez-Ruiz JM; Fernandez-Velasco DA
    J Mol Biol; 2009 Mar; 386(4):1153-66. PubMed ID: 19154739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guanidine hydrochloride can induce amyloid fibril formation from hen egg-white lysozyme.
    Vernaglia BA; Huang J; Clark ED
    Biomacromolecules; 2004; 5(4):1362-70. PubMed ID: 15244452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin kappa light chain and its amyloidogenic mutants: a molecular dynamics study.
    Nowak M
    Proteins; 2004 Apr; 55(1):11-21. PubMed ID: 14997536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual structures in the acid-unfolded states of Vlambda6 proteins affect amyloid fibrillation.
    Mishima T; Ohkuri T; Monji A; Kanemaru T; Abe Y; Ueda T
    J Mol Biol; 2009 Oct; 392(4):1033-43. PubMed ID: 19647748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of partly folded states in the equilibrium unfolding of ervatamin A: spectroscopic description of the native, intermediate, and unfolded states.
    Nallamsetty S; Dubey VK; Pande M; Ambasht PK; Jagannadham MV
    Biochimie; 2007 Nov; 89(11):1416-24. PubMed ID: 17658212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A partially structured region of a largely unstructured protein, Plasmodium falciparum merozoite surface protein 2 (MSP2), forms amyloid-like fibrils.
    Yang X; Adda CG; Keizer DW; Murphy VJ; Rizkalla MM; Perugini MA; Jackson DC; Anders RF; Norton RS
    J Pept Sci; 2007 Dec; 13(12):839-48. PubMed ID: 17883245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congo red populates partially unfolded states of an amyloidogenic protein to enhance aggregation and amyloid fibril formation.
    Kim YS; Randolph TW; Manning MC; Stevens FJ; Carpenter JF
    J Biol Chem; 2003 Mar; 278(12):10842-50. PubMed ID: 12529361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid fibrils formation and amorphous aggregation in concanavalin A.
    Vetri V; Canale C; Relini A; Librizzi F; Militello V; Gliozzi A; Leone M
    Biophys Chem; 2007 Jan; 125(1):184-90. PubMed ID: 16934387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggregation of a slow-folding mutant of a beta-clam protein proceeds through a monomeric nucleus.
    Ignatova Z; Gierasch LM
    Biochemistry; 2005 May; 44(19):7266-74. PubMed ID: 15882065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solvational tuning of the unfolding, aggregation and amyloidogenesis of insulin.
    Grudzielanek S; Jansen R; Winter R
    J Mol Biol; 2005 Aug; 351(4):879-94. PubMed ID: 16051271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Charge differences between in vivo deposits in immunoglobulin light chain amyloidosis and non-amyloid light chain deposition disease.
    Kaplan B; Livneh A; Gallo G
    Br J Haematol; 2007 Mar; 136(5):723-8. PubMed ID: 17223908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.